Stefanie Avril

2.8k total citations
45 papers, 1.7k citations indexed

About

Stefanie Avril is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Stefanie Avril has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 18 papers in Oncology and 13 papers in Reproductive Medicine. Recurrent topics in Stefanie Avril's work include Ovarian cancer diagnosis and treatment (13 papers), Cancer Cells and Metastasis (5 papers) and Cancer-related molecular mechanisms research (5 papers). Stefanie Avril is often cited by papers focused on Ovarian cancer diagnosis and treatment (13 papers), Cancer Cells and Metastasis (5 papers) and Cancer-related molecular mechanisms research (5 papers). Stefanie Avril collaborates with scholars based in United States, Germany and United Kingdom. Stefanie Avril's co-authors include Holger Bronger, Marion Kiechle, Steffen Hauptmann, Raymond W. Redline, Katrin Friedrich, Manfred Schmitt, Norbert Avril, Barbara Schmalfeldt, Alex Y. Huang and Joseph Nthale and has published in prestigious journals such as Science, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Stefanie Avril

44 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefanie Avril United States 22 801 649 418 415 264 45 1.7k
Heini Lassus Finland 25 830 1.0× 1.0k 1.6× 555 1.3× 184 0.4× 487 1.8× 44 2.0k
Kazushi Shigemasa Japan 27 636 0.8× 840 1.3× 441 1.1× 271 0.7× 236 0.9× 50 1.8k
A. Ahr Germany 19 1.1k 1.4× 666 1.0× 759 1.8× 300 0.7× 76 0.3× 56 1.9k
Boris Winterhoff United States 21 462 0.6× 749 1.2× 418 1.0× 142 0.3× 554 2.1× 56 1.5k
Jason Madore Australia 25 1.6k 2.0× 756 1.2× 320 0.8× 1.0k 2.5× 153 0.6× 32 2.5k
Esra A. Akbay United States 23 582 0.7× 910 1.4× 299 0.7× 292 0.7× 64 0.2× 34 1.6k
Elisabeth Mueller‐Holzner Austria 18 679 0.8× 1.5k 2.3× 523 1.3× 141 0.3× 153 0.6× 31 2.1k
Susanna L. Cooke United Kingdom 16 473 0.6× 583 0.9× 481 1.2× 126 0.3× 337 1.3× 21 1.3k
Liancheng Zhu China 20 226 0.3× 657 1.0× 307 0.7× 238 0.6× 222 0.8× 72 1.1k
Brian P. Adley United States 22 347 0.4× 724 1.1× 313 0.7× 149 0.4× 124 0.5× 30 1.5k

Countries citing papers authored by Stefanie Avril

Since Specialization
Citations

This map shows the geographic impact of Stefanie Avril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Avril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Avril more than expected).

Fields of papers citing papers by Stefanie Avril

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Avril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Avril. The network helps show where Stefanie Avril may publish in the future.

Co-authorship network of co-authors of Stefanie Avril

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Avril. A scholar is included among the top collaborators of Stefanie Avril based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Avril. Stefanie Avril is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ta, Hieu Minh, Keman Zhang, Tyler Alban, et al.. (2024). LRIG1 engages ligand VISTA and impairs tumor-specific CD8 + T cell responses. Science Immunology. 9(95). eadi7418–eadi7418. 23 indexed citations
2.
Khalighi, Sirvan, Germán Corredor, Pingfu Fu, et al.. (2024). Computational pathology identifies immune-mediated collagen disruption to predict clinical outcomes in gynecologic malignancies. SHILAP Revista de lepidopterología. 4(1). 2–2. 7 indexed citations
3.
Zhang, Keman, Amin Zakeri, Tyler Alban, et al.. (2023). 935 VISTA regulates the differentiation of myeloid-derived suppressor cells by STAT3-dependent modulation of arginase-1 and iNOS expression and mitochondrial function. SHILAP Revista de lepidopterología. A1039–A1039. 1 indexed citations
4.
Yoshida, Akihiro, Polly J. Phillips‐Mason, Stefanie Avril, et al.. (2022). Non-phosphorylatable cyclin D1 mutant potentiates endometrial hyperplasia and drives carcinoma with Pten loss. Oncogene. 41(15). 2187–2195. 6 indexed citations
5.
Schrock, Morgan S., Darcie D. Seachrist, Stefanie Avril, et al.. (2020). LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance. Cancer Research. 80(8). 1693–1706. 29 indexed citations
6.
Taylor, Sarah E., Caitlin M. O’Connor, Zhizhi Wang, et al.. (2019). The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis. Cancer Research. 79(16). 4242–4257. 42 indexed citations
7.
Sadraei, Nooshin Hashemi, Yan Feng, Lingling Du, et al.. (2018). High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung Cancer. Lung Cancer. 126. 48–54. 5 indexed citations
8.
Avril, Stefanie, Melanie Boxberg, Barbara Schmalfeldt, et al.. (2017). CXCR3 mediates ascites-directed tumor cell migration and predicts poor outcome in ovarian cancer patients. Oncogenesis. 6(5). e331–e331. 26 indexed citations
9.
Bronger, Holger, et al.. (2017). MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Research and Treatment. 162(3). 511–521. 48 indexed citations
10.
Avril, Stefanie. (2017). Histopathological markers of treatment response and recurrence risk in ovarian cancers and borderline tumors. Der Pathologe. 38(S2). 180–191. 2 indexed citations
11.
Valls, Laia, Chaitra Badve, Stefanie Avril, et al.. (2016). FDG-PET imaging in hematological malignancies. Blood Reviews. 30(4). 317–331. 37 indexed citations
12.
Avril, Stefanie, Raymond F. Muzic, Donna Plecha, et al.. (2016). 18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer. Journal of Nuclear Medicine. 57(Supplement 1). 34S–39S. 91 indexed citations
13.
Hauptmann, S., et al.. (2014). Histologische Malignitätsgraduierung des Ovarialkarzinoms. Der Pathologe. 35(5). 497–503. 4 indexed citations
14.
Sizemore, Steven T., Gina M. Sizemore, Christine N. Booth, et al.. (2014). Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors. Breast Cancer Research and Treatment. 146(1). 25–40. 27 indexed citations
15.
Malinowsky, Katharina, et al.. (2013). Variation in Cell Signaling Protein Expression May Introduce Sampling Bias in Primary Epithelial Ovarian Cancer. PLoS ONE. 8(10). e77825–e77825. 8 indexed citations
16.
Avril, Stefanie. (2013). microRNA-Expression während der Brustentwicklung und in Mammakarzinomen. Der Pathologe. 34(S2). 195–200. 2 indexed citations
17.
Avril, Stefanie, Michaela Aubele, Tibor Schuster, et al.. (2013). Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers. British Journal of Cancer. 109(9). 2347–2355. 10 indexed citations
18.
Avril, Stefanie, Ellen J. Hahn, Katja Specht, et al.. (2012). Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome. Gynecologic Oncology. 127(3). 516–524. 19 indexed citations
19.
Schuster, Tibor, Katharina Malinowsky, Holger Bronger, et al.. (2012). Intratumoral Heterogeneity of MicroRNA Expression in Breast Cancer. Journal of Molecular Diagnostics. 14(4). 376–384. 37 indexed citations
20.
Malinowsky, Katharina, et al.. (2012). Common Protein Biomarkers Assessed by Reverse Phase Protein Arrays Show Considerable Intratumoral Heterogeneity in Breast Cancer Tissues. PLoS ONE. 7(7). e40285–e40285. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heini Lassus Breakdown of academic impact, for papers by Kazushi Shigemasa Breakdown of academic impact, for papers by A. Ahr Breakdown of academic impact, for papers by Boris Winterhoff Breakdown of academic impact, for papers by Jason Madore Breakdown of academic impact, for papers by Esra A. Akbay Breakdown of academic impact, for papers by Elisabeth Mueller‐Holzner Breakdown of academic impact, for papers by Susanna L. Cooke Breakdown of academic impact, for papers by Liancheng Zhu Breakdown of academic impact, for papers by Brian P. Adley
Rankless by CCL
2026